Wild, P. S. | bioRxiv Science

bioRxiv2026

GenesetDiseaseDrugNetwork (GDDN): a web server for disease enrichment and drug prioritization

SummaryOmics technologies profile thousands of genetic and molecular features to provide a comprehensive and quantitative measure of the cellular state. Transcriptomics and proteomics have, especially, guided discoveries of the most important biomarkers and therapeutic targets. By virtue of ongoing developments in single-cell and spatial technologies, fields of targeted therapeutics and personalized medicine are rapidly advancing. However, downstream functional analysis and disease association still remain daunting tasks in bioinformatics. We address these challenges with the GenesetDiseaseDrugNetwork (GDDN) web server. GDDN facilitates functional discovery by connecting gene-sets to enriched diseases and their corresponding therapeutics in a single step. Using a ranking system that incorporates regulatory impact, specificity, and potency, GDDN effectively prioritizes drugs with the highest clinical relevance. Our platform facilitates the interpretation of omics outputs into disease associations and personalized drug identification. Availability and ImplementationThe GDDN web server is implemented in R Shiny and is freely accessible at https://cbdm-01.zdv.uni-mainz.de/shiny/piyusmor/GDDN/, supporting all major web browsers. Contactpiyusmor@uni-mainz.de Supplementary informationSupplementary data is available at Bioinformatics online.

bioinformatics↗

bioRxiv2024

Choroid plexus enlargement in acute neuroinflammation is tightly interrelated to the tyrosine receptor signalling

The choroid plexus (ChP) plays a crucial function in neuroinflammation of the central nervous system and in the immune response of the brain during neurodegeneration. Recent studies described a massive ChP enlargement in patients with multiple sclerosis (MS) and active disease courses, but also in several other neuroinflammatory and neurodegenerative conditions. Nevertheless, the exact basis and pathophysiology behind ChP hypertrophy remains unclear. This study was designed to evaluate the association of cerebrospinal fluid (CSF) proteomic spectra with brain MRI-derived volumetric measures of ChP in two independent cohorts of MS patients, and to translationally validate the related molecular mechanisms in the transcriptomic analysis of the ChP properties in a mouse model of experimental autoimmune encephalomyelitis (EAE). Our analysis revealed five enriched proteins (NTRK2, ADAM23, SCARB2, CPM, CNTN5) significantly associated with the ChP volumes in both of the MS cohorts. These proteins relate closely to mechanisms of cellular communication, function (e.g. transmembrane tyrosine receptor signalling (RTK) and vascular endothelial growth) and pathways involved in the regulation of cellular plasticity (e.g. neuron differentiation, axonal remodelling and myelin regulation) as depicted by molecular function analysis and validation of the results in the transcriptome from ChP tissue specific for EAE. This work provides conclusive new evidence for the role of ChP in the context of neuroinflammation and neurodegeneration, demonstrating the intriguing relationships between ChP enlargement, CSF dynamics, and the development of neuroinflammatory and neurodegenerative diseases. Our results are encouraging for the development of new therapeutic avenues (i.e. targeting RTK signalling). One sentence summaryTyrosine receptor signalling is tightly associated with choroid plexus enlargement and is key in CSF dynamics during a neuroinflammatory attack in MS

neuroscience↗